drugset / Trial / NCT03609099
Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response
Phase 4
Unknown
424 enrolled
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica · collabMiquel Ferrer - Investigator Coordinator · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Non-inferiority, multicenter, prospective double-blind, randomized clinical trial of two parallel groups. The randomization between the 2 study groups will be carried out according to a scheme generated by a computer program, in blocks of 6 and stratified by centers. The antibiotic treatment will be evaluated during 5 days compared to the usual antibiotic treatment for more than 7 days in patients with community-acquired pneumonia with a Pneumonia Severity Index IV-V severity score who present an adequate response in the first 4 days of hospital antibiotic treatment.
Timeline
- Start
- 2019-02-15
- Primary completion
- 2020-11-15
- Completion
- 2021-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |